Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study.
17 auth. D. Oh, Kyung-Hun Lee, Dae-Won Lee, J. Yoon, Tae-Yong Kim, J. Bang, Ah-Rong Nam, K. Oh, Jae-Min Kim, Young S. Lee, ... V. Guthrie, P. McCoon, Weimin Li, Song Wu, Qu Zhang, M. Rebelatto, J. W. Kim